Losing a pregnancy can have traumatic psychological impacts on women. When left untreated, they can have detrimental and long-lasting effects on the health and well-being of these women and their families.

Among the key takeaways from the AHIP 2023 conference: The health care system must do a better job of working together to provide people with the right behavioral health care resources at the right time, with measurable outcomes.

A behind-the-scenes look at how Express Scripts Pharmacy by Evernorth gets medication from our door to yours.

Plan sponsors should be aware of the important health implications the “fourth trimester” of pregnancy holds for new mothers.

By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.

More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex challenge.

Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.

GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population of the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-related health challenges within their member population.